Dihydroergotamine, propranolol and the beta adrenergic receptors of fat cells.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology / Q000294:innervation / Q000378:metabolism*; D002001:Adipose Tissue, Brown / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology*; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D005990:Glycerol / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011984:Sensory Receptor Cells / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000502:physiology*; D013963:Thyroid Hormones / Q000378:metabolism; D014044:Tolbutamide / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D005227:Fatty Acids; D013963:Thyroid Hormones; D000324:Adrenocorticotropic Hormone; D014044:Tolbutamide; D011433:Propranolol; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D005990:Glycerol; D004878:Ergotamine; D011188:Potassium; D002118:Calcium; D004837:Epinephrine